Home/Pipeline/Comprehensive Barrett’s Esophagus Test (CBEST™)

Comprehensive Barrett’s Esophagus Test (CBEST™)

Barrett's Esophagus with Dysplasia

CommercialActive

Key Facts

Indication
Barrett's Esophagus with Dysplasia
Phase
Commercial
Status
Active
Company

About Pathnostics

Pathnostics is a private, commercial-stage diagnostics company specializing in transformative testing for complicated, recurrent, and persistent UTIs through its Guidance® platform. The company's core innovation combines multiplex PCR with Pooled Antibiotic Susceptibility Testing (P-AST™) to identify pathogens and their antibiotic resistance profiles more accurately than standard culture, particularly for polymicrobial infections. Operating from a CAP-accredited, CLIA-certified lab, Pathnostics serves urologists, gastroenterologists, OB/GYNs, and primary care physicians, with a growing portfolio that includes tests for Barrett's Esophagus. It is positioned to address critical needs in antibiotic stewardship and improved patient outcomes in chronic infectious diseases.

View full company profile